Updating results

756 results for end of life care Sort: Relevance | Date

End of life care for infants, children and young people with life-limiting conditions: planning and management (NG61)

Evidence-based recommendations on managment of end of life care for infants, children and young people (aged 0–17 years) with life-limiting conditions

NICE guideline Published December 2016

End of life care for people with life-limiting conditions

Everything NICE has said about the care of people with a progressive life-limiting condition who are at the end of their life in an interactive flowchart

NICE Pathway Published March 2017 Last updated September 2017

End of life care for adults in the last year of life: service delivery

In development [GID-CGWAVE0799] Expected publication date: 18 July 2018

NICE guideline In development

Managing breakthrough pain:- What is the acceptability, safety, and effectiveness of different types of opioid analgesia for breakthrough pain in children and young people with life-limiting conditions who are having end of life care in the community?

of opioid analgesia for breakthrough pain in children and young people with life-limiting conditions who are having end of...

Research recommendation Published February 2017

The diagnosis of levels of distress for end of life residents in care homes

Shared learning Published October 2014 Last updated April 2015

Care of dying adults in the last days of life (NG31)

Evidence-based recommendations on the clinical care of dying adults at the very end of life

NICE guideline Published December 2015

Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation (CG135)

Evidence-based recommendations on identifying potential organ donors and obtaining consent for deceased organ donation for transplantation

Clinical guideline Published December 2011 Last updated December 2016

Motor neurone disease: assessment and management (NG42)

Evidence-based recommendations for assessing and managing motor neurone disease (MND), also known as amyotrophic lateral sclerosis (ALS).

NICE guideline Published February 2016

Motor neurone disease

Everything NICE has said on assessing and managing motor neurone disease in adults in an interactive flowchart

NICE Pathway Published November 2013 Last updated September 2017

Transition between inpatient hospital settings and community or care home settings for adults with social care needs (NG27)

Evidence-based recommendations on the transition between inpatient hospital settings and community or care homes for adults with social care needs.

NICE guideline Published December 2015

Care of dying adults in the last days of life (QS144)

Evidence-based statements to deliver quality improvements in the care of dying adults (aged 18 and over) in the last 2 to 3 days of life

Quality standard Published March 2017

Myeloma: diagnosis and management (NG35)

Evidence-based recommendations on the diagnosing and managing of myeloma in people aged 16 and over.

NICE guideline Published February 2016

Idiopathic pulmonary fibrosis in adults: diagnosis and management (CG163)

Evidence-based recommendations on diagnosing and managing idiopathic pulmonary fibrosis (IPF) (hardening of the lungs) in adults

Clinical guideline Published June 2013 Last updated May 2017

Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease (TA449)

Evidence-based recommendations on everolimus (Afinitor) and sunitinib (Sutent) for treating neuroendocrine tumours in adults

Technology appraisal guidance Published June 2017

Endocrine, nutritional and metabolic conditions

Everything NICE has said on endocrine, nutritional and metabolic conditions in an interactive flowchart

NICE Pathway Published December 2014 Last updated October 2017

Crohn's disease: management (CG152)

Evidence-based recommendations on managing Crohn's disease in adults, young people and children

Clinical guideline Published October 2012 Last updated May 2016

Preventing falls in older people

Everything NICE has said on assessing and preventing falls in older people in the community and in hospital, in an interactive flowchart

NICE Pathway Published June 2013 Last updated September 2017

Osteoarthritis

Everything NICE has said on the care and management of osteoarthritis in adults in an interactive flowchart

NICE Pathway Published February 2014 Last updated November 2017

Sorafenib for treating advanced hepatocellular carcinoma (TA474)

Evidence-based recommendations on sorafenib (Nexavar) for treating advanced hepatocellular carcinoma (liver cancer) in adults

Technology appraisal guidance Published September 2017

Everolimus for advanced renal cell carcinoma after previous treatment (TA432)

Evidence-based recommendations on everolimus (Afinitor) for advanced renal cell carcinoma (kidney cancer) after previous treatment

Technology appraisal guidance Published February 2017

Palliative care for adults: strong opioids for pain relief (CG140)

Evidence-based recommendations on strong opioids for pain relief for adults having palliative (end of life) care

Clinical guideline Published May 2012 Last updated August 2016

Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment (TA333)

Evidence-based recommendations on axitinib (Inlyta) for treating advanced renal cell carcinoma (RCC) (kidney cancer) when prior systemic treatment has failed

Technology appraisal guidance Published February 2015

Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts (TA399)

Evidence-based recommendations on azacitidine (Vidaza) for treating acute myeloid leukaemia (AML) with more than 30% bone marrow blasts

Technology appraisal guidance Published July 2016

Dental checks: intervals between oral health reviews (CG19)

Evidence-based recommendations on the intervals between routine dental examinations (oral health reviews) for all age groups

Clinical guideline Published October 2004

Cirrhosis in over 16s: assessment and management (NG50)

Evidence-based recommendations on diagnosing and managing cirrhosis (scarring of the liver) in over 16s

NICE guideline Published July 2016

Blinatumomab for previously treated Philadelphia-chromosome-negative acute lymphoblastic leukaemia (TA450)

Evidence-based recommendations on blinatumomab (Blincyto) for treating Philadelphia-chromosome-negative precursor B-cell acute lymphoblastic leukaemia in adults

Technology appraisal guidance Published June 2017

Surgical site infections: prevention and treatment (CG74)

Evidence-based recommendations on preventing and treating surgical site infections for adults, young people and children who are having a surgical procedure

Clinical guideline Published October 2008 Last updated February 2017

Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia (TA451)

Evidence-based recommendations on ponatinib (Iclusig) for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia in adults

Technology appraisal guidance Published June 2017

Trifluridine–tipiracil for previously treated metastatic colorectal cancer (TA405)

Evidence-based recommendations on trifluridine–tipiracil (Lonsurf) for previously treated metastatic colorectal cancer in adults

Technology appraisal guidance Published August 2016

Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin (TA402)

Evidence-based recommendations on pemetrexed (Alimta) for locally advanced or metastatic non-squamous non-small-cell lung cancer in adults who have had..

Technology appraisal guidance Published August 2016

Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens (TA423)

Evidence-based recommendations on eribulin (Halaven) for treating locally advanced or metastatic breast cancer after 2 or more types of chemotherapy

Technology appraisal guidance Published December 2016

Idiopathic pulmonary fibrosis

Everything NICE has said on diagnosing and managing suspected idiopathic pulmonary fibrosis in adults in an interactive flowchart

NICE Pathway Published June 2013 Last updated June 2017

Older people with social care needs and multiple long-term conditions (NG22)

Evidence-based recommendations on the planning and delivery of social care and support for older people who have multiple long-term conditions.

NICE guideline Published November 2015

Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma (TA396)

Evidence-based recommendations on trametinib (Mekinist) with dabrafenib (Tafinlar) for treating unresectable or metastatic melanoma with a BRAF V600 mutation

Technology appraisal guidance Published June 2016

Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib (TA427)

Evidence-based recommendations on pomalidomide (Imnovid) for multiple myeloma previously treated with lenalidomide and bortezomib in adults

Technology appraisal guidance Published January 2017

Atezolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (TA492)

Evidence-based recommendations on atezolizumab (Tecentriq) for treating locally advanced or metastatic urothelial (transitional cell; bladder) cancer in adults

Technology appraisal guidance Published December 2017

Nivolumab for previously treated advanced renal cell carcinoma (TA417)

Evidence-based recommendations on nivolumab (Opdivo) for previously treated advanced renal cell carcinoma (RCC/kidney cancer) in adults

Technology appraisal guidance Published November 2016 Last updated November 2017

Mental wellbeing and independence in older people

Everything NICE has said on promoting mental wellbeing and independence in older people over 65 in an interactive flowchart

NICE Pathway Published November 2012 Last updated December 2016

Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel (TA391)

Evidence-based recommendations on cabazitaxel (Jevtana) for prostate cancer that has come back after it was treated with docetaxel.

Technology appraisal guidance Published May 2016 Last updated August 2016

Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen (TA316)

Evidence-based recommendations on enzalutamide (Xtandi) for metastatic hormone-relapsed prostate cancer previously treated with a docetaxel-containing regimen

Technology appraisal guidance Published July 2014